glp 1 agonists vs sglt2 inhibitors and GLP-1 receptor agonists: a sound combination Benefits of treatment with SGLT2i

2025;8(1):p

Nat Rev Nephrol 12(2):7381 Muskiet MHA, Tonneijck L, Smits MM, Kramer MHH, Heerspink HJL, van Raalte DH (2015) Pleiotropic effects of type 2 diabetes management strategies on renal risk factors

GLP-1 receptor agonists, SGLT2 inhibitors and DPP-4 inhibitors GLP-1 receptor agonists, sodium glucose co-transporter-2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors reduce the risk of MACE compared to placebo

Just two capsules daily-ideally 30 minutes before your biggest meal-help reduce cravings and support long-term metabolic health

The analysis identified two main symptom categories that may warrant further investigation

Likewise, another study shows that Exenatide alleviates mitochondrial dysfunction and cognitive impairment in 5FAD mice (84)